Search

Your search keyword '"Taffé P"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Taffé P" Remove constraint Author: "Taffé P"
233 results on '"Taffé P"'

Search Results

1. A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial

5. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

12. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

13. Extended biasplot command to assess bias, precision, and agreement in method comparison studies

14. Ageing with HIV: medication use and risk for potential drug–drug interactions

19. Ageing with HIV: medication use and risk for potential drug-drug interactions

20. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

21. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

23. Sodium intake and blood pressure in children and adolescents: protocol for a systematic review and meta-analysis

24. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

25. Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

26. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

27. Impact of an interdisciplinary strategy on antibiotic use: a prospective controlled study in three hospitals

28. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

29. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

30. A two-year retrospective review of the determinants of pre-hospital analgesia administration by alpine helicopter emergency medical physicians to patients with isolated limb injury.

31. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

32. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

33. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

34. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

35. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery

36. Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy

38. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

39. Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals

41. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

42. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

43. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders

45. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.

46. Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes.

47. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection

48. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations

49. Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study

50. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland

Catalog

Books, media, physical & digital resources